dapsone has been researched along with losartan potassium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Woodruff, AW | 1 |
| Bjarnason, B; Flosadóttir, E | 1 |
| Mobacken, H | 1 |
1 review(s) available for dapsone and losartan potassium
| Article | Year |
|---|---|
Recent work concerning anemia in the tropics.
Topics: Adolescent; Adult; Anemia; Anemia, Hypochromic; Anemia, Megaloblastic; Animals; Child; Child, Preschool; Dapsone; Drug Combinations; Erythropoietin; Female; Hookworm Infections; Humans; Infant; Iron-Dextran Complex; Leishmaniasis, Visceral; Macaca mulatta; Malaria; Male; Mice; Middle Aged; Protein-Energy Malnutrition; Pyrimethamine; Schistosomiasis; Socioeconomic Factors; Tropical Medicine; Trypanosomiasis, African | 1982 |
3 other study(ies) available for dapsone and losartan potassium
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Full dapsone dose made possible by control of anaemia with darbepoetin-alpha.
Topics: Aged, 80 and over; Anemia, Hemolytic; Dapsone; Darbepoetin alfa; Dose-Response Relationship, Drug; Erythropoietin; Hematinics; Hemolysis; Humans; Immunosuppressive Agents; Male | 2008 |
Commentary to a paper by Flosadóttir & Bjarnason on full dapsone dose made possible by control of anaemia with darbepoetin-alpha.
Topics: Aged, 80 and over; Anemia, Hemolytic; Dapsone; Darbepoetin alfa; Dose-Response Relationship, Drug; Erythropoietin; Hematinics; Humans; Immunosuppressive Agents; Male | 2008 |